Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis-Reference-Cited by-同舟云学术

Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis

Published:2018-05-15 Issue:7 Volume:15 Page:2570-2583
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Smith Lindsay¹,Serrano Dolores R.²,Mauger Marion¹,Bolás-Fernández Francisco³,Dea-Ayuela Maria Auxiliadora⁴,Lalatsa Aikaterini¹^ORCID

Affiliation:

1. Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, White Swan Road, Portsmouth PO1 2DT, U.K.

2. Departament of Pharmaceutics and Food Technology and Instituto Universitario de Farmacia Industrial (IUFI), School of Pharmacy, University Complutense, Avenida Complutense, 28040 Madrid, Spain

3. Departament of Microbiology and Parasitology, School of Pharmacy, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain

4. Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Edificio Seminario s/n, 46113 Moncada, Valencia, Spain

Funder

Sir Halley Stewart Trust

Research and Development Fund, University of Portsmouth

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00097

Reference77 articles.

1. World Health Organization. Why are some tropical diseases called “neglected”? http://www.who.int/features/qa/58/en/ (accessed November 8, 2017).

2. Novel therapeutic strategies for treatment of visceral leishmaniasis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review;Beilstein Journal of Nanotechnology;2024-01-04

2. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase;European Journal of Pharmaceutical Sciences;2024-01

3. Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy;Biomacromolecules;2023-11-25

4. Recent Updates on Multifunctional Nanomaterials as Antipathogens in Humans and Livestock: Classification, Application, Mode of Action, and Challenges;Molecules;2023-11-20

5. Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022);Expert Opinion on Therapeutic Patents;2023-03-04